UBS O'Connor’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-196,703
Closed -$17K 988
2022
Q3
$17K Sell
196,703
-19,754
-9% -$2K ﹤0.01% 890
2022
Q2
$19K Sell
216,457
-50,558
-19% -$10.5K ﹤0.01% 913
2022
Q1
$84K Buy
267,015
+4,719
+2% +$1.72K ﹤0.01% 821
2021
Q4
$136K Sell
262,296
-5,962
-2% -$3.4K ﹤0.01% 790
2021
Q3
$153K Hold
268,258
﹤0.01% 762
2021
Q2
$192K Buy
268,258
+68,266
+34% +$38.7K ﹤0.01% 731
2021
Q1
$100K Buy
+199,992
New +$116K ﹤0.01% 752

Other funds holding EQHA.WS

UBS O'Connor's EQHA.WS Position: Q4 2022 in Review

UBS O'Connor sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 196,703 shares — an estimated $17K sold.

UBS O'Connor first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $192K in Q2 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • UBS O'Connor reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 196,703 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $17K.
  • UBS O'Connor first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
  • UBS O'Connor's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $192K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.